CTGF AS AN OBJECTIVE FOR MICROALBUMINURIA THERAPY IN PATIENTS WITH DIABETIC NEFROPATIA.

摘要

Use of an agent that inhibits CTGF in the manufacture of a medicament for treating microalbuminuria in a patient with incipient diabetic nephropathy, where the agent is an anti-connective tissue growth factor (CTGF) antibody, anti-CTGF anti-sense nucleic acid or specific siRNA of CTGF, miRNA or ribozyme.